A Case Report and Overview of Familial Cerebral Cavernous Malformation Pathogenesis in an Adult Patient by Arul, BS, Manu K. et al.
JHN Journal
Volume 13 | Issue 2 Article 3
Spring 2018
A Case Report and Overview of Familial Cerebral
Cavernous Malformation Pathogenesis in an Adult
Patient
Manu K. Arul, BS
State University of New York, Upstate Medical University
Omaditya Khanna
Thomas Jefferson University, omaditya.khanna@jefferson.edu
Michael R. Gooch, MD
Thomas Jefferson University, reid.gooch@jefferson.edu
Follow this and additional works at: https://jdc.jefferson.edu/jhnj
Let us know how access to this document benefits you
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
JHN Journal by an authorized administrator of the Jefferson Digital Commons. For more information, please contact:
JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Arul, BS, Manu K.; Khanna, Omaditya; and Gooch, MD, Michael R. (2018) "A Case Report and Overview of Familial Cerebral
Cavernous Malformation Pathogenesis in an Adult Patient," JHN Journal: Vol. 13 : Iss. 2 , Article 3.
DOI: https://doi.org/10.29046/JHNJ.013.2.003
Available at: https://jdc.jefferson.edu/jhnj/vol13/iss2/3
17JHN JOURNAL 
Famililal Cavernous Malformations
an unremitting headache starting one-
week prior. She describes the headache 
as bifrontal and similar to a headache 
she had during her prior presentation. 
She rated the pain as an 8 out of 10. A 
head CT was performed and a new left 
frontoparietal intraparenchymal hemor-
rhage was discovered separate from her 
previous resection site. When the patient 
was admitted to our institution for further 
care and evaluation.
Other than her previous craniotomy for 
a hemorrhagic cavernous malforma-
tion, she has no other significant surgical 
history. Her family medical history is 
pertinent for hypertension in her mother. 
She was not taking any medications, and 
claims not to smoke, drink alcohol, or use 
illicit substances. An MRI was performed 
after her resection in 2016, which did not 
demonstrate new lesions. 
Her physical exam demonstrated that she 
was awake, alert, and oriented to person, 
place, and time. She had no gross cogni-
tive or neurologic deficits; cranial nerve 
testing of CN II-XII showed normal func-
tioning, her strength was 5/5 in upper and 
lower extremities, and her sensation was 
intact. Her gait was normal, without distur-
bances; she did not demonstrate pronator 
drift. An MRI was performed, revealing 
new lesions in the right cerebellum as well 
as left frontoparietal lesion. 
The patient was brought to the OR for 
resection of the lesion the following 
day. She underwent a left frontoparietal 
craniotomy and resection of the lesion 
without complications. Her post-opera-
tive recovery had no complications and 
she was discharged from the hospital on 
post-operative day3.
DISCUSSION
Cerebral cavernous malformations (CCM) 
are low flow, vascular malformations of 
vessel-like channels, filled with blood in 
A Case Report and Overview of Familial 
Cerebral Cavernous Malformation 
Pathogenesis in an Adult Patient
OBJECTIVE 
We present a case of a 39 year-old woman who presented with a solitary cavernous 
malformation hemorrhage without any other lesions, and subsequently presented 
several months later with a new hemorrhage from a de novo lesion. We discuss 
mechanisms of paradominant inheritance and haploinsufficiency to describe phenotype 
expression of familial cavernous malformations.
CASE DESCRIPTION 
The patient presented with unremitting headaches, who had a known history of a 
solitary cerebral cavernous malformation (CCM) for which she underwent resection 
several months prior with no evidence of any other CCM lesions seen on post-operative 
MRI. She has no history of whole brain radiation, family history of cavernous malforma-
tions, or prior head trauma. During this hospital visit, she was found to have develop 
two new lesions in the left fronto-parietal lobe and cerebellum. She was treated with 
surgical resection of the left frontoparietal lesion, and recovered fully. It is of interest 
that a patient approaching her fourth decade of life would start to develop formation 
of multiple de novo cavernous malformations, especially with an absent family history. 
Paradominant Inheritance and haploinsufficiency are two proposed models of inheri-
tance that can be related to this patient’s disease progression.
CONCLUSION 
The case illustrates an atypical clinical course of a patient with familial cerebral 
cavernous malformations with delayed formation of de novo lesions.
INTRODUCTION
Cerebral Cavernous Malformation is a vascular disease of the brain with solitary and 
familial mechanisms.1 The patient of interest presented to the hospital with headaches and 
a past history of CCM one year prior, with new hypodense lesions on a head CT scan, most 
likely cavernous malformations. The possibility of hereditary CCM development during 
adulthood and lesion multiplicity through the mechanisms of paradominant inheritance 
and haplo-insufficiency is described. Understanding these modes of inheritance as well 
as the genetic pathology can aid in genetic counseling as well as developing disease 
modifying treatments apart from surveillance and surgery.
CASE
The patient is a 39 year-old female with a history of a solitary cavernous malformation 
for which she underwent a left parieto-occipital craniotomy for resection in 2016. At 
that time, a post-operative MRI did not reveal any other lesions suspicious for cavernous 
malformations (including GRE sequence). She presented to an outside hospital with 
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and resultant microhemorrhage due 
to venous hypertension.1 Nearly half of 
sporadic CCMs are associated with an 
adjacent DVA; in contrast, hereditary 
CCMs develop in near absence of DVAs.3
Our patient had no history of cavernous 
malformation until her first occurrence 
one year prior to this presentation. In 
between that time and now, two new 
cavernous malformations formed. Her 
work up and medical history did not have 
any associated DVA or other vascular 
abnormality. The question remains to 
why she had developed a symptomatic 
cavernoma close to four decades into 
her life, and then two more within a 
year’s time. There are several cases of 
multifocal sporadic lesions, where CCM 
mutations accounted for roughly 60% of 
observed pathologic findings.11 Baciga-
luppi’s review et al sheds light on various 
molecular pathways that are responsible 
for vascular development and pathologic 
variations in cerebral cavernous malfor-
mation.3 Two of the foremost theories on 
the inheritance of this disease, as well as 
other vascular malformation pathologies 
are those of paradominant inheritance 
and haploinsufficiency.
Haploinsufficiency
Haploinsufficiency is defined by non-
inheritance of a gene or loss of function 
mutation that leads to insufficient genetic 
expression of a wild-type phenotype. 
Diseases such as Angelmann syndrome 
and Ehlers-Danlos Syndrome are char-
acteristic of haploinsufficiency. It has 
been proposed that haploinsufficiency 
manifests through various ways in CCM, 
such as inadequate protein production for 
endothelial junction formation, causing 
the pseudovascular formation character-
istic of CCM.12 Though this can be seen 
as an adequate explanation for disease 
mechanism, it would not fit the presenta-
tion of our patient as haploinsufficiency 
would indicate disease progression since 
birth, which was not the case here.
Paradominant Inheritance: 
Paradominant inheritance mimics the 
two hit hypothesis initially described 
by Knudson to describe the tumor 
suppressor gene mechanism.3 Paradomi-
nant inheritance constitutes a congenital 
inheritance of a nonfunctional gene, and 
from a CCM1 mutation is derived from 
the KRIT1 gene, that is suggested to play 
a role in cell adhesion and migration, 
directly influencing the endothelial cells 
which form and support vasculature.5 
CCM2 is described as playing a role 
akin to that of CCM1, especially in the 
sequestration and signaling of the KRIT1 
involved pathway. This acts through the 
MGC4607 gene, malcavernin; it has been 
shown that both loci can act together in 
a CCM1/2 complex to influence vascular 
development.6 CCM3 can be described 
as “tumor suppressor like,” where dele-
tions in CCM3 can lead to proliferation 
and resistance to apoptosis, shown by 
Louvi et al in a mouse model.7 A zebrafish 
model by Yoruk et al further supports that 
the CCM3 model behaves separately from 
the CCM1/2 pathway, and even contrib-
utes to a phenotypically different pattern 
of vascular development.8 Furthermore, 
their study showed CCM3 worked in 
conjunction with GCKIII, which can be 
implicated in pharmaceutical therapy.
Originally, Zabramski et al described 
familial cavernous malformation as a 
dynamic disease, with families exhibiting 
similar symptomatology among genera-
tions.9 Our patient, however, did not 
recall family members with her disease 
or symptomatology. It is possible that 
family members had asymptomatic 
lesions, as Zabramski’s research points 
out that actively bleeding cavernomas 
are most likely to be symptomatic and 
discovered. In addition, Denier et al had 
demonstrated that CCM3 genotypes 
generally had less familial expression 
of the disease. Though it is understood 
which genes play a role in disease devel-
opment, the underlying mechanism of 
expression is not concretely understood 
(See figure 1).
De novo Cerebral Cavernous 
Malformation 
De novo cavernomas have been reported 
to have underlying risk factors, such as 
cranial radiation, coexistent vascular 
malformations, and hormonal factors. 
Head injury, reactive angiogenesis, and 
viral infections can also play a role in 
producing cavernomas. 10 However, their 
exact pathogenesis remains unknown. 
Gross’ meta-analyses proposed that de 
novo CCMs develop from developmental 
venous anomalies (DVA), venous stasis, 
various stages of degradation. They lack 
the smooth muscle support of normal 
vessels without any intervening brain 
parenchyma, and are generally clustered 
and dilated.1,2 Cavernous malforma-
tions account for 5 to 15% percent of all 
vascular malformations in the CNS, and 
are prone to rupture due to stressors or 
changes in blood pressure.2 Cavernous 
malformations can be hereditary (familial) 
or sporadic, and are usually discovered 
through a symptomatic presentation 
of hemorrhage.2 The most common 
presenting symptoms include head-
ache, seizures, and focal neurologic 
deficits; seizures are the most common 
symptom in 40-60% of presenting 
cavernous malformations. The presence 
of multiple lesions seen on a cerebral 
magnetic-resonance image is indica-
tive of the familial form of the disease, 
and 20-50% of affected individuals will 
develop symptoms between the second 
and fifth decade of life.3
We report a patient approaching her 
4th decade of life with a history of 
one prior symptomatic cavernous 
malformation the previous year, 
presenting now for a separate symp-
tomatic, actively bleeding cavernous 
malformation. Following her previous 
resection in 2016, post-operative MRI 
did not reveal new lesions or disease 
foci. Now, CT and MRI reveals two 
distinct lesions, newly developed 
within a year’s time, reflecting an 
atypical clinical course of the familial 
form of cerebral cavernous malforma-
tion disease. 
Familial Cerebral Cavernous 
Malformation Development
Familial or hereditary CCM occurs from 
mutations involving 3 loci: CCM1, CCM2, 
and CCM3. CCM1 mutations account for 
roughly 70% of familial cerebral cavernous 
malformations.4 It is proposed that the 
various mutations within these genes 
might affect angiogenesis and endo-
thelial cell morphogenesis, deteriorating 
vascular stability.4 There are close to one 
hundred CCM1 mutations that contribute 
to disease development.5 In a 2007 
review, Brouillard and Vikkula described 
numerous roles the CCM1 locus plays in 
cerebral vascular development, as well as 
its possible significance in arterial-venous 
differentiation. The main pathogenesis 
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CONCLUSION
Here we have presented the case of a 
39 year-old female who was diagnosed 
and treated for a de novo formation of 
a symptomatic cavernous malformation, 
with only one prior cavernous malforma-
tion one year prior. The acuity of lesion 
genesis and her late presentation of the 
disease can address the reasoning toward 
the pathogenesis of familial cavernous 
malformation as resembling a two-hit 
mechanism, resembling similarities 
with paradominant inheritance, with 
the second gene knockout occurring 
recently. Further genetic analysis of this 
patient and her family could possibly 
illuminate her mutations and inheritance 
pattern.
there is difference between paradominant 
inheritance and two hit mechanism; the 
two hit mechanism conveys the disease 
is autosomal dominant and shows partial 
penetrance after one hit, while a two hit 
would show full penetrance.
This patient’s development of CCM 
lesions in the absence of venous anoma-
lies, alongside the manifestation of new 
lesions in a short period of time mimic 
a pathologic mechanism resembling 
that of paradominant inheritance. Her 
generation of multiple lesions after a 
year’s time could indicate that a second 
gene was compromised in the past few 
years, fulfilling a two-hit mechanism. 
Further genetic testing on tissue sample 
can illuminate which CCM mutations led 
to her disease, and could further illumi-
nate the variations in CCM1, CCM2, and 
CCM3 pathogenesis.
then a somatic second hit during life. 
However, the patient preserves a normal 
phenotype until the second hit is seques-
tered, thus the “paradominance.” Though 
there are 3 CCM genes, a loss of func-
tion by two hit mechanism to any one 
gene can lead to lesion development.3,5,13 
Furthermore, it has been pointed out that 
one hit to any gene can express vascular 
abnormalities, such as weakened endo-
thelial vascular lining.6 These genetic 
disruptions can come to light through 
any trauma, injury, or radiation the brain 
vasculature. See figure 2.
Paradominant inheritance could shed 
light on our patient’s disease develop-
ment as she has no prior evidence of 
CCM development apart from her prior 
presentation; her rapid multifocal lesion 
development imitates similar disease 
processes of tumor suppressor genes, 
such as breast tumor multiplicity in BRCA 
mutations. It should be understood that 
Poor Endothelial Adhesion and Cell-Cell 
Junction formation, other unknown 
endothelial cell mechanisms
Multi-Loci Interaction 
Disrupted
Loss of apoptopic 
control
Cavernous 
Malformation 
Development
CCM2
CCM1
CCM3
Figure 1.
This simplistic diagram illustrates the individual CCM loci contribution to disease development, as well as the complex pathways that have 
been shown in various studies. A black bar indicates loss of function. Knockouts or non-inheritance of functional loci have been shown to 
result in CCM development and other abnormal vascular phenotypes.6–8,13,14
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Figure 2.
This Venn Diagram portrays the theoretical differences and similarities between paradominant 
inheritance and haploinsufficiency. Paradominant inheritance has been theorized to be the 
underlying mode of inheritance for other anomalies that appear to develop sporadically.15,16
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